an Unexpected Consequence of Electronic Cigarette Use
Individual Clinical
Safety
Adverse Effects
McCauley (2012)
a Mixed Methods Pilot Study on the Short-Term Physiological Effects of Vaping and attitudes Regarding Its Use and health Effects in Samples of Young adults.
Individual Clinical
Safety
Adverse Effects
McClelland (2020)
Effects on vital signs after twenty minutes of vaping compared to people exposed to second-hand vapor.
Individual Clinical
Safety
Adverse Effects
McClelland (2020)
The Immediate Physiological Effects of E-Cigarette Use and Exposure to Secondhand E-Cigarette Vapor.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
McClelland (2021)
Recent updates on biomarkers of exposure and systemic toxicity in e-cigarette users and EVaLI.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
McDonough (2021)
a Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
McEwan (2022)
Reduced plasma phosphatidylethanolamines in e-cigarette, or vaping, product use-associated lung injury (EVaLI).
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of The User
McGraw (2022)
anxiety Sensitivity and Emotion Dysregulation in Dual and Exclusive E-Cigarette Users.
Individual Clinical
Safety
Adverse Effects
McLeish (2021)
E-Cigarette Use and Future Cigarette Initiation among Never Smokers and Relapse among Former Smokers in the PaTh Study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
McMillen (2019)
Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and acrolein
Individual Clinical
Biomarkers
Biomarkers Of Exposure
McRobbie (2015)